Indeed, LADA patients exhibit significant variability in the rate of beta-cell destruction, varying degrees of preservation of endogenous insulin secretion, heterogeneous patterns of islet autoimmunity, as well as varying degrees of insulin resistance, probably as a consequence of differences in genetic and immune factors [70,71]. The gene discussed is INS; the disease is Insulin resistance.